DE69921589D1 - Peptide zum Nachweis von HIV-1-Guppe O - Google Patents

Peptide zum Nachweis von HIV-1-Guppe O

Info

Publication number
DE69921589D1
DE69921589D1 DE69921589T DE69921589T DE69921589D1 DE 69921589 D1 DE69921589 D1 DE 69921589D1 DE 69921589 T DE69921589 T DE 69921589T DE 69921589 T DE69921589 T DE 69921589T DE 69921589 D1 DE69921589 D1 DE 69921589D1
Authority
DE
Germany
Prior art keywords
peptides
group
hiv
detection
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69921589T
Other languages
English (en)
Other versions
DE69921589T2 (de
Inventor
Leys Robert De
Jian Zheng
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ortho Clinical Diagnostics Inc
Original Assignee
Ortho Clinical Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/433,428 external-priority patent/US6149910A/en
Application filed by Ortho Clinical Diagnostics Inc filed Critical Ortho Clinical Diagnostics Inc
Application granted granted Critical
Publication of DE69921589D1 publication Critical patent/DE69921589D1/de
Publication of DE69921589T2 publication Critical patent/DE69921589T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
    • G01N2333/155—Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
    • G01N2333/16—HIV-1, HIV-2
    • G01N2333/162—HIV-1, HIV-2 env, e.g. gp160, gp110/120, gp41, V3, peptid T, DC4-Binding site

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • AIDS & HIV (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE69921589T 1998-11-30 1999-11-29 Peptide zum Nachweis von HIV-1-Guppe O Expired - Lifetime DE69921589T2 (de)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US11029298P 1998-11-30 1998-11-30
US110292 1998-11-30
US11913899P 1999-02-08 1999-02-08
US119138 1999-02-08
US09/433,428 US6149910A (en) 1999-11-04 1999-11-04 Peptides for the detection of HIV-1 group O
US433428 1999-11-04

Publications (2)

Publication Number Publication Date
DE69921589D1 true DE69921589D1 (de) 2004-12-09
DE69921589T2 DE69921589T2 (de) 2005-11-10

Family

ID=35140296

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69921589T Expired - Lifetime DE69921589T2 (de) 1998-11-30 1999-11-29 Peptide zum Nachweis von HIV-1-Guppe O

Country Status (7)

Country Link
US (1) US20060216699A1 (de)
EP (1) EP1013766B1 (de)
JP (1) JP4481404B2 (de)
AT (1) ATE281525T1 (de)
CA (2) CA2290217C (de)
DE (1) DE69921589T2 (de)
HK (1) HK1028065A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8431145B2 (en) * 2004-03-19 2013-04-30 Abbott Laboratories Multiple drug delivery from a balloon and a prosthesis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986006414A1 (en) * 1985-04-29 1986-11-06 Genetic Systems Corporation Synthetic antigens for the detection of aids-related disease
US5695927A (en) * 1988-03-31 1997-12-09 The University Of Arizona, Department Of Internal Medicine, Section Of Hematology And Oncology Monoclonal antibodies specific for HIV and the hybridomas for production thereof
DK0591914T4 (da) * 1992-10-06 2010-05-25 Siemens Healthcare Diagnostics Retrovirus fra HIV-gruppen og dets anvendelse
CA2202408C (fr) * 1994-10-20 2012-03-06 Pierre Charneau Sequences nucleotidiques d'antigenes retroviraux vih-1 groupe (ou sous-groupe) o
FR2731013B1 (fr) * 1995-02-27 1997-05-16 Inst Nat Sante Rech Med Vih-1 de groupe o, fragments desdits virus, ainsi que leurs applications
CN1215082C (zh) * 1997-04-09 2005-08-17 比奥-拉德巴斯德公司 可用于检测o组hiv－1病毒感染的生物试验的合成肽

Also Published As

Publication number Publication date
EP1013766A3 (de) 2003-01-29
CA2290217C (en) 2010-01-12
DE69921589T2 (de) 2005-11-10
CA2676762A1 (en) 2000-05-30
ATE281525T1 (de) 2004-11-15
CA2290217A1 (en) 2000-05-30
US20060216699A1 (en) 2006-09-28
HK1028065A1 (en) 2001-02-02
EP1013766A2 (de) 2000-06-28
EP1013766B1 (de) 2004-11-03
JP4481404B2 (ja) 2010-06-16
JP2000157268A (ja) 2000-06-13
CA2676762C (en) 2015-12-29

Similar Documents

Publication Publication Date Title
KR960702753A (ko) Hiv 전이 저해하는 합성 펩티드
ATE308558T1 (de) Hiv-1- und hiv-2-peptide zur hemmung von mit membranfusionen in zusammenhang stehenden phänomenen, einschliesslich der übertragung von hiv
DK0673948T3 (da) Peptider, der stammer fra et retrovirus fra HIV-gruppen, og deres anvendelse
DE3587512T2 (de) Hüllenantigene vom menschlichen Immunodefizienz-Virus und deren Verwendungen.
DE3855947T2 (de) Peptide mit den immunologischen Eigenschaften von HIV-2
DK11789A (da) Rekombinante vaccinia-vira
ATE154610T1 (de) Synthetische vom hiv-gp120-env-protein abgeleitete peptide und ihre anwendung
WO1991009872A3 (en) Hiv-1 env fragment fusion protein
DK1278534T3 (da) Fremgangsmåder og sammensætninger til svækkelse af multiplikationen af HIV-1
BR0010720A (pt) Peptìdeos de neisseria antigênicos
DE69130396T2 (de) Vergrössertes western blot format und ein immunotestverfahren für die bestimmung von viralen antikörpern
FR2669338B1 (de)
ATE435034T1 (de) Expression und charakterisierung eines hiv-1 hüllproteins, das mit einer breitreaktiven neutralisierenden antikörperantwort assoziiert ist.
DE69921589D1 (de) Peptide zum Nachweis von HIV-1-Guppe O
ATE343592T1 (de) Gegen ein peptid, das ein kryptisches epitop von gp41 aus hiv-1 nachahmt gerichteter antikörper
WO2000049038A3 (de) Synthetische peptide des regulatorischen virusproteins r (vpr) des humanen immundefizienzvirus typ 1 (hiv-1) und ihre verwendung
ATE283279T1 (de) Therapeutische inhaltsstoffe
CA2057612A1 (en) Selected peptides of the group-specific antigen (gag) of human immunodeficiency virus (hiv), the preparation and use thereof
GB2336844A (en) Anti-hiv peptides and proteins
ATE105190T1 (de) Ein b-epitop des huellglykoproteins eines retrovirus und ein t-epitop eines anderen proteins dieses retrovirus enthaltende zusammensetzung.
ATE119166T1 (de) An hiv relatierte peptide.
RU2000106709A (ru) Пептиды-имитаторы консервативного эпитопа белка gp41 вируса иммунодефицита человека типа 1, узнаваемого вируснейтрализующими моноклональными антителами 2f5
TH62264A (th) Hiv เพพไทด์, แอนติเจน องค์ประกอบวัคซีน, ชุดสำเร็จรูปอิมมูโนแอสเสย์ และวิธีสำหรับตรวจหาแอนติบอดีที่ชักนำโดย hiv
TH65071A (th) เพพไทด์ควบคุม และอนุเคราะห์ hiv แอนติเจน องค์ประกอบวัคซีนชุดสำเร็จรูปอิมมูโนแอสเสย์และวิธีการของการตรวจหาแอนติบอดีที่ถูกชักนำโดย hiv
RU2000121960A (ru) Пептидный антиген, полученный из белка х вируса гепатита b (варианты), ph-чувствительная липосома для индукции клеточного иммунитета против вируса гепатита b

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: BOEHMERT & BOEHMERT, 28209 BREMEN